AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Authorization of Gene Editing Therapy Cascavii
This chapter discusses the authorization of a gene editing treatment called Cascavii for sickle cell disease and transfusion dependent beta thalassemia, highlighting its promising results and potential applications. It also mentions clinical trial data and the presentation of NAN 101 for the treatment of congestive heart failure.